Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Martin Vogelbaum currently holds 390,000 shares of Cara Therapeutics, Inc. (CARA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Vogelbaum has been a net buyer of CARA stock. They have purchased $4.4M and sold $320.3K worth of shares.
Martin Vogelbaum's most recent insider trade was on Jun 4, 2024, when they sold 390,000 shares at $0.00 per share.
Martin Vogelbaum serves as Executive at Cara Therapeutics, Inc. (CARA). They have executed 19 insider transactions totaling $4.8M over their tenure at the company.
Martin Vogelbaum holds the position of Executive at Cara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Martin Vogelbaum has shown a buying trading pattern, with $4.4M in total purchases and $320.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Martin Vogelbaum was on Feb 5, 2014, when they purchased $2.5M worth of CARA shares. This transaction involved 225,818 shares at $11.00 per share.
Martin Vogelbaum currently owns 390,000 shares of Cara Therapeutics, Inc. (CARA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Martin Vogelbaum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martin Vogelbaum has 19 Form 4 filings on record as an insider at Cara Therapeutics, Inc..
Set alerts for Martin Vogelbaum and 40,000+ other insiders.